Nothing Special   »   [go: up one dir, main page]

Dabbagh et al., 2021 - Google Patents

Identification of the SHREK family of proteins as broad-spectrum host antiviral factors

Dabbagh et al., 2021

View HTML
Document ID
14201319060032755218
Author
Dabbagh D
He S
Hetrick B
Chilin L
Andalibi A
Wu Y
Publication year
Publication venue
Viruses

External Links

Snippet

Mucins and mucin-like molecules are highly glycosylated, high-molecular-weight cell surface proteins that possess a semi-rigid and highly extended extracellular domain. P- selectin glycoprotein ligand-1 (PSGL-1), a mucin-like glycoprotein, has recently been found …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Similar Documents

Publication Publication Date Title
Percher et al. Mother-to-child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother-to-child transmission
Gross et al. Molecular mechanisms of HTLV-1 cell-to-cell transmission
Le Tortorec et al. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction
Focosi et al. Analysis of immune escape variants from antibody-based therapeutics against COVID-19: a systematic review
Jones et al. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors
Xu et al. Human defensins inhibit SARS-CoV-2 infection by blocking viral entry
Kalinichenko et al. HIV-1 and HTLV-1 transmission modes: Mechanisms and importance for virus spread
Niu et al. TIM-1 promotes Japanese encephalitis virus entry and infection
Anand et al. Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins
McDonald Dendritic cells and HIV-1 trans-infection
Fernández-Ortega et al. Identification of vimentin as a potential therapeutic target against HIV infection
De Brogniez et al. Determinants of the bovine leukemia virus envelope glycoproteins involved in infectivity, replication and pathogenesis
He et al. PSGL-1 inhibits the incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins into pseudovirions and impairs pseudovirus attachment and infectivity
Xu et al. Human immunodeficiency viruses pseudotyped with SARS-CoV-2 spike proteins infect a broad spectrum of human cell lines through multiple entry mechanisms
Marin et al. HIV-1 fusion with CD4+ T cells is promoted by proteins involved in endocytosis and intracellular membrane trafficking
Dabbagh et al. Identification of the SHREK family of proteins as broad-spectrum host antiviral factors
Beaudoin-Bussières et al. SARS-CoV-2 accessory protein ORF8 decreases antibody-dependent cellular cytotoxicity
Hudák et al. Syndecan-4 is a key facilitator of the SARS-CoV-2 delta variant’s superior transmission
Kant et al. Quantifying anti-HIV envelope-specific antibodies in plasma from HIV infected individuals
Matsuura et al. Three YXXL sequences of a bovine leukemia virus transmembrane protein are independently required for fusion activity by controlling expression on the cell membrane
Su et al. Adding an Artificial Tail—Anchor to a Peptide-Based HIV-1 Fusion Inhibitor for Improvement of Its Potency and Resistance Profile
Tan et al. A novel CXCR4 targeting protein SDF-1/54 as an HIV-1 entry inhibitor
Munoz et al. Host molecule incorporation into hiv virions, potential influences in hiv pathogenesis
Zou et al. Transportin-3 facilitates uncoating of influenza a virus
Noailly et al. Antiviral activities of HIV-1-specific human broadly neutralizing antibodies are isotype-dependent